Ascletis Pharma is expanding the production of rionavir oral tablets and the oral direct-acting antiviral R&D pipeline to treat Covid-19.
Related Keywords
China , Jinzi Wu , China National Medical Products Administration , National Medical Products Administration ,
vimarsana.com © 2020. All Rights Reserved.